FOXP3 and cranioectodermal dysplasia: In active CeD, the loss of intestinal barrier integrity allows microbial-derived butyrate to synergize with IFN-γ to modulate alternative splicing of FOXP3, favoring the expression of shorter FOXP3 Delta 2 isoform, which lacks exon 2.